Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
28
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kozick Linda | Director | 21 | $0 | $0 | 2026-03-03 |
| Giordano Michael F | Director | 24 | $0 | $634.5K | 2026-03-03 |
| Lyons-Williams Lori | Director | 12 | $0 | $0 | 2026-03-03 |
| Wong Brian Russell | President and CEO | 37 | $360.1K | $801.0K | 2026-03-03 |
| Braunstein Scott | Director | 4 | $0 | $0 | 2026-03-03 |
| Brockstedt Dirk G. | Chief Scientific Officer | 95 | $0 | $1.84M | 2026-03-03 |
| Young Rodney KB | Chief Financial Officer | 26 | $52.6K | $0 | 2026-03-03 |
| Dombkowski Ashley L. | Director | 4 | $0 | $0 | 2026-03-03 |
| GRAY MARY ANN | Director | 28 | $0 | $0 | 2026-03-03 |
| HO WILLIAM | Chief Medical Officer | 143 | $0 | $2.93M | 2025-06-20 |
| Robbins Wendye | Director | 66 | $602.0K | $0 | 2025-03-31 |
| Column Group LLC | 10% Owner | 12 | $13.34M | $2.43M | 2024-12-23 |
| Column Group IV, LP | 10% Owner | 4 | $0 | $0 | 2024-12-23 |
| RIEFLIN WILLIAM JL | Director | 16 | $258.2K | $0 | 2024-05-23 |
| Kutzkey Tim | 10% Owner | 3 | $23.7K | $12.25M | 2022-05-25 |
| COLUMN GROUP II, LP | 10% Owner | 15 | $23.7K | $6.71M | 2022-05-25 |
| Column Group IV-A, LP | 10% Owner | 6 | $13.66M | $0 | 2022-05-24 |
| Ponoi Management, LLC | 10% Owner | 4 | $323.7K | $0 | 2022-05-24 |
| Ponoi Capital II, LP | 10% Owner | 23 | $7.50M | $319.4K | 2021-09-27 |
| Ponoi II Management, LLC | 10% Owner | 14 | $0 | $20.03M | 2021-09-13 |
| Svennilson Peter | Director, 10% Owner | 30 | $0 | $34.01M | 2021-08-24 |
| Lam Karen C | VP, Finance and Controller | 8 | $0 | $115.7K | 2021-01-28 |
| KPCB XV Founders Fund, LLC | 10% Owner | 3 | $0 | $0 | 2020-10-16 |
| GUTHART LEO | 10% Owner | 1 | $0 | $0 | 2020-05-26 |
| Topspin Biotech Fund II, L.P. | 10% Owner | 4 | $4.98M | $0 | 2019-11-04 |
| KPCB XV Associates, LLC | 10% Owner | 8 | $0 | $0 | 2019-11-04 |
| GOEDDEL DAVID V | Director, 10% Owner | 13 | $7.50M | $0 | 2019-11-04 |
| Gleason Tom P | President/CEO | 1 | $0 | $0 | 2011-06-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Braunstein Scott | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 25,000 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,917 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 417 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 521 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 521 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,083 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 218,250 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 8,334 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 25,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 371,875 | — | $0 | 265,625 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 31,250 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 37,500 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 18,750 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 10,417 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 7,500 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2026-03-03 | 2026-03-05 | 34,375 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 9,375 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 64,375 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 58,333 | — | $0 | 41,667 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 7,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,225 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,035 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 3,125 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,500 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 6,250 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 6,876 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 80,250 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 11,251 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 8,501 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 69,271 | — | $0 | 49,479 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 8,125 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 7,500 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2026-03-03 | 2026-03-05 | 17,501 | — | $0 | 0 | SEC↗ |
| Dombkowski Ashley L. | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 25,000 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 799 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 402 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 824 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 498 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,813 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 484 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 560 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,072 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 7,650 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 478 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,813 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| Kozick Linda | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | U Tender | 2026-03-03 | 2026-03-05 | 64,102 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | U Tender | 2026-03-03 | 2026-03-05 | 4,648 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | U Tender | 2026-03-03 | 2026-03-05 | 3,304 | — | $0 | 0 | SEC↗ |
| Dombkowski Ashley L. | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| Giordano Michael F | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| GRAY MARY ANN | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| Lyons-Williams Lori | Director | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| Dombkowski Ashley L. | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| Kozick Linda | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| Lyons-Williams Lori | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| GRAY MARY ANN | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| Giordano Michael F | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| Braunstein Scott | Director | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2025-06-21 | 2025-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Dombkowski Ashley L. | Director | A Award deriv | 2025-06-21 | 2025-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-06-20 | 2025-06-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-06-20 | 2025-06-24 | 118,750 | — | $0 | 118,750 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2025-06-20 | 2025-06-24 | 637,500 | — | $0 | 637,500 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2025-06-20 | 2025-06-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kozick Linda | Director | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| Lyons-Williams Lori | Director | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| Giordano Michael F | Director | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2025-03-31 | 2025-04-02 | 61,202 | $1.06 | $64.9K | 61,202 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2025-03-31 | 2025-04-02 | 49,432 | $1.06 | $52.4K | 49,432 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2025-01-30 | 2025-02-03 | 1,746,000 | — | $0 | 1,746,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-01-30 | 2025-02-03 | 515,000 | — | $0 | 515,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-01-30 | 2025-02-03 | 642,000 | — | $0 | 642,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2025-01-30 | 2025-02-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Column Group LLC | 10% Owner | J Other deriv | 2024-12-23 | 2024-12-23 | 1,352,008 | — | $0 | 1,352,008 | SEC↗ |
| Column Group LLC | 10% Owner | J Other deriv | 2024-12-23 | 2024-12-23 | 1,599,417 | — | $0 | 1,599,417 | SEC↗ |
| Column Group IV, LP | 10% Owner | J Other deriv | 2024-12-23 | 2024-12-23 | 1,352,008 | — | $0 | 1,352,008 | SEC↗ |
| Column Group IV, LP | 10% Owner | J Other deriv | 2024-12-23 | 2024-12-23 | 1,599,417 | — | $0 | 1,599,417 | SEC↗ |
| Column Group LLC | 10% Owner | J Other | 2024-12-23 | 2024-12-23 | 1,599,417 | — | $0 | 0 | SEC↗ |
| Column Group LLC | 10% Owner | J Other | 2024-12-23 | 2024-12-23 | 1,352,008 | — | $0 | 50,000 | SEC↗ |
| Column Group IV, LP | 10% Owner | J Other | 2024-12-23 | 2024-12-23 | 1,352,008 | — | $0 | 50,000 | SEC↗ |
| Column Group IV, LP | 10% Owner | J Other | 2024-12-23 | 2024-12-23 | 1,599,417 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 20,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 50,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 56,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 75,000 | — | $0 | 0 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 75,000 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 56,000 | — | $0 | 56,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 7,807 | — | $0 | 7,807 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 20,000 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 7,807 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 56,000 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 55,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 275,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 250,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 60,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 300,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 150,000 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | D To issuer deriv | 2024-11-13 | 2024-11-15 | 83,333 | — | $0 | 0 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-11-13 | 2024-11-15 | 83,333 | — | $0 | 83,333 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 90,000 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 68,000 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 65,000 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 60,000 | — | $0 | 0 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-11-13 | 2024-11-15 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2024-11-13 | 2024-11-15 | 140,000 | — | $0 | 0 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2024-05-23 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| Giordano Michael F | Director | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| Kozick Linda | Director | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| Lyons-Williams Lori | Director | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2024-03-28 | 2024-04-01 | 11,871 | $7.58 | $90.0K | 11,871 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2024-03-28 | 2024-04-01 | 8,574 | $7.58 | $65.0K | 8,574 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2024-03-28 | 2024-04-01 | 6,925 | $7.58 | $52.5K | 6,925 | SEC↗ |
| Wong Brian Russell | PRESIDENT AND CEO | A Award deriv | 2024-01-31 | 2024-02-01 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-01-31 | 2024-02-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-01-31 | 2024-02-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| HO WILLIAM | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-31 | 2024-02-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-01-05 | 2024-01-08 | 898 | $22.78 | $20.5K | 27,820 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2023-12-29 | 2024-01-02 | 8,000 | — | $0 | 7,690 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2023-12-29 | 2024-01-02 | 8,000 | $6.18 | $49.4K | 27,070 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-12-21 | 2023-12-22 | 2,500 | $21.68 | $54.2K | 15,020 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-11-28 | 2023-11-29 | 1,500 | $13.72 | $20.6K | 17,520 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-10-03 | 2023-10-04 | 2,500 | $15.77 | $39.4K | 18,789 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-08-18 | 2023-08-22 | 2,500 | $18.92 | $47.3K | 21,289 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-07-28 | 2023-08-03 | 460 | — | $0 | 1,841 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-07-28 | 2023-08-03 | 460 | $12.00 | $5.5K | 23,789 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-06-23 | 2023-06-27 | 920 | — | $0 | 2,301 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-06-23 | 2023-06-27 | 920 | $12.00 | $11.0K | 23,329 | SEC↗ |
| Giordano Michael F | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| Kozick Linda | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| Lyons-Williams Lori | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-04-19 | 2023-04-20 | 5,000 | $18.88 | $94.4K | 20,992 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-04-13 | 2023-04-14 | 460 | — | $0 | 3,802 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-04-13 | 2023-04-14 | 460 | $12.00 | $5.5K | 22,381 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-03-31 | 2023-04-10 | 4,477 | $14.52 | $65.0K | 4,477 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2023-03-31 | 2023-04-10 | 3,616 | $14.52 | $52.5K | 3,616 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2023-03-31 | 2023-04-10 | 6,026 | $14.52 | $87.5K | 6,026 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2023-03-14 | 2023-03-15 | 400 | $18.48 | $7.4K | 14,300 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2023-03-14 | 2023-03-15 | 600 | $19.95 | $12.0K | 14,900 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2023-03-14 | 2023-03-15 | 2,500 | $20.05 | $50.1K | 6,500 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2023-03-14 | 2023-03-15 | 1,500 | $18.75 | $28.1K | 13,900 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-03-07 | 2023-03-13 | 5,000 | $29.62 | $148.1K | 25,532 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-03-03 | 2023-03-06 | 460 | — | $0 | 3,681 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-03-03 | 2023-03-06 | 460 | $12.00 | $5.5K | 30,532 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 56,000 | — | $0 | 56,000 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Wong Brian Russell | President and CEO | A Award deriv | 2023-01-31 | 2023-02-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Young Rodney KB | Chief Financial Officer | A Award deriv | 2023-01-31 | 2023-02-02 | 68,000 | — | $0 | 68,000 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-01-24 | 2023-01-26 | 5,000 | $30.00 | $150.0K | 30,072 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2023-01-19 | 2023-01-20 | 5,000 | $25.56 | $127.8K | 35,072 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-01-12 | 2023-01-17 | 1,042 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2023-01-12 | 2023-01-17 | 1,380 | — | $0 | 4,601 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-01-12 | 2023-01-17 | 1,380 | $12.00 | $16.6K | 40,072 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2023-01-12 | 2023-01-17 | 1,042 | $6.30 | $6.6K | 38,692 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2023-01-05 | 2023-01-09 | 742 | $21.97 | $16.3K | 19,070 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-12-29 | 2022-12-30 | 5,000 | $18.03 | $90.2K | 37,650 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-11-28 | 2022-11-29 | 5,000 | $17.87 | $89.3K | 42,650 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-11-02 | 2022-11-03 | 5,000 | $22.32 | $111.6K | 47,650 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-10-13 | 2022-10-14 | 2,000 | $21.52 | $43.0K | 52,650 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-10-03 | 2022-10-04 | 347 | — | $0 | 1,042 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-10-03 | 2022-10-04 | 460 | — | $0 | 5,981 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-10-03 | 2022-10-04 | 347 | $6.30 | $2.2K | 54,190 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-10-03 | 2022-10-04 | 460 | $12.00 | $5.5K | 54,650 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-09-01 | 2022-09-06 | 348 | — | $0 | 1,389 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-09-01 | 2022-09-06 | 460 | — | $0 | 6,441 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-09-01 | 2022-09-06 | 460 | $12.00 | $5.5K | 53,843 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-09-01 | 2022-09-06 | 348 | $6.30 | $2.2K | 53,383 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-08-30 | 2022-08-31 | 2,500 | $28.13 | $70.3K | 53,035 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-08-12 | 2022-08-15 | 347 | — | $0 | 1,737 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-08-12 | 2022-08-15 | 460 | — | $0 | 6,901 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-08-12 | 2022-08-15 | 460 | $12.00 | $5.5K | 55,535 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-08-12 | 2022-08-15 | 347 | $6.30 | $2.2K | 55,075 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-07-11 | 2022-07-13 | 1,381 | — | $0 | 7,361 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-07-11 | 2022-07-13 | 1,041 | — | $0 | 2,084 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-07-11 | 2022-07-13 | 2,000 | $19.95 | $39.9K | 52,306 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-07-11 | 2022-07-13 | 1,041 | $6.30 | $6.6K | 53,347 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-07-11 | 2022-07-13 | 1,381 | $12.00 | $16.6K | 54,728 | SEC↗ |
| Giordano Michael F | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Kozick Linda | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Lyons-Williams Lori | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Kutzkey Tim | 10% Owner | P Buy | 2022-05-25 | 2022-05-27 | 1,837 | $12.45 | $22.9K | 1,236,261 | SEC↗ |
| Kutzkey Tim | 10% Owner | P Buy | 2022-05-25 | 2022-05-27 | 63 | $12.45 | $784 | 42,189 | SEC↗ |
| COLUMN GROUP II, LP | 10% Owner | P Buy | 2022-05-25 | 2022-05-27 | 63 | $12.45 | $784 | 42,189 | SEC↗ |
| COLUMN GROUP II, LP | 10% Owner | P Buy | 2022-05-25 | 2022-05-27 | 1,837 | $12.45 | $22.9K | 1,236,261 | SEC↗ |
| Ponoi Management, LLC | 10% Owner | P Buy | 2022-05-24 | 2022-05-25 | 15,776 | $12.00 | $189.3K | 1,234,424 | SEC↗ |
| Ponoi Management, LLC | 10% Owner | P Buy | 2022-05-24 | 2022-05-25 | 538 | $12.00 | $6.5K | 42,126 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-24 | 2022-05-25 | 15,776 | $12.00 | $189.3K | 1,234,424 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-24 | 2022-05-25 | 538 | $12.00 | $6.5K | 42,126 | SEC↗ |
| Ponoi Management, LLC | 10% Owner | P Buy | 2022-05-23 | 2022-05-25 | 9,898 | $12.50 | $123.7K | 1,218,648 | SEC↗ |
| Ponoi Management, LLC | 10% Owner | P Buy | 2022-05-23 | 2022-05-25 | 338 | $12.50 | $4.2K | 41,588 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-23 | 2022-05-25 | 9,898 | $12.50 | $123.7K | 1,218,648 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-23 | 2022-05-25 | 338 | $12.50 | $4.2K | 41,588 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 400 | $10.62 | $4.2K | 4,000 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 600 | $10.49 | $6.3K | 3,600 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 1,000 | $10.51 | $10.5K | 3,000 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 500 | $11.30 | $5.7K | 1,800 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 2,500 | $11.80 | $29.5K | 13,800 | SEC↗ |
| Robbins Wendye | Director | P Buy | 2022-05-10 | 2022-05-12 | 2,000 | $10.54 | $21.1K | 11,300 | SEC↗ |
| Young Rodney KB | Chief Financial Officer | P Buy | 2022-05-10 | 2022-05-12 | 5,000 | $10.53 | $52.6K | 10,084 | SEC↗ |
| Column Group LLC | 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 1,208,750 | $10.67 | $12.90M | 1,208,750 | SEC↗ |
| Column Group LLC | 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 41,250 | $10.67 | $440.1K | 41,250 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 41,250 | $10.67 | $440.1K | 41,250 | SEC↗ |
| Column Group IV-A, LP | 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 1,208,750 | $10.67 | $12.90M | 1,208,750 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2022-05-04 | 2022-05-05 | 720 | $15.05 | $10.8K | 19,812 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-04-11 | 2022-04-12 | 920 | — | $0 | 8,742 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2022-04-11 | 2022-04-12 | 1,290 | — | $0 | 2,113 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2022-04-11 | 2022-04-12 | 1,357 | — | $0 | 15,690 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-04-11 | 2022-04-12 | 920 | $12.00 | $11.0K | 54,306 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2022-04-11 | 2022-04-12 | 2,647 | $23.05 | $61.0K | 19,812 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2022-04-11 | 2022-04-12 | 2,647 | $6.18 | $16.4K | 22,459 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-04-06 | 2022-04-07 | 3,000 | $22.96 | $68.9K | 53,386 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-04-04 | 2022-04-04 | 695 | — | $0 | 3,125 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-04-04 | 2022-04-04 | 695 | $6.30 | $4.4K | 56,386 | SEC↗ |
| Giordano Michael F | Director | A Award deriv | 2022-03-31 | 2022-04-04 | 3,213 | $16.80 | $54.0K | 3,213 | SEC↗ |
| RIEFLIN WILLIAM JL | Director | A Award deriv | 2022-03-31 | 2022-04-04 | 5,207 | $16.80 | $87.5K | 5,207 | SEC↗ |
| Robbins Wendye | Director | A Award deriv | 2022-03-31 | 2022-04-04 | 3,124 | $16.80 | $52.5K | 3,124 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2022-03-31 | 2022-04-04 | 3,868 | $16.80 | $65.0K | 3,868 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2022-03-11 | 2022-03-14 | 2,648 | — | $0 | 17,047 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2022-03-11 | 2022-03-14 | 2,648 | $6.18 | $16.4K | 22,460 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2022-03-11 | 2022-03-14 | 2,648 | $23.91 | $63.3K | 19,812 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-02-28 | 2022-02-28 | 3,000 | $18.79 | $56.4K | 55,691 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2022-02-11 | 2022-02-14 | 2,647 | — | $0 | 19,695 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2022-02-11 | 2022-02-14 | 2,647 | $22.47 | $59.5K | 19,812 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2022-02-11 | 2022-02-14 | 2,647 | $6.18 | $16.4K | 22,459 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-02-08 | 2022-02-09 | 347 | — | $0 | 3,820 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-02-08 | 2022-02-09 | 460 | — | $0 | 9,662 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-02-08 | 2022-02-09 | 460 | $12.00 | $5.5K | 58,691 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-02-08 | 2022-02-09 | 347 | $6.30 | $2.2K | 58,231 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | A Award deriv | 2022-01-28 | 2022-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | A Award deriv | 2022-01-28 | 2022-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Wong Brian Russell | President and CEO | A Award deriv | 2022-01-28 | 2022-02-14 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Young Rodney KB | Chief Financial Officer | A Award deriv | 2022-01-28 | 2022-02-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-01-13 | 2022-01-14 | 3,000 | $30.67 | $92.0K | 57,884 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2022-01-11 | 2022-01-13 | 2,648 | — | $0 | 22,342 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2022-01-11 | 2022-01-13 | 2,648 | $6.18 | $16.4K | 22,460 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2022-01-11 | 2022-01-13 | 2,648 | $32.16 | $85.2K | 19,812 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2022-01-05 | 2022-01-06 | 2,000 | $40.00 | $80.0K | 60,884 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-01-04 | 2022-01-06 | 1,737 | — | $0 | 0 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-01-04 | 2022-01-06 | 1,736 | — | $0 | 4,167 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise deriv | 2022-01-04 | 2022-01-06 | 2,305 | — | $0 | 10,122 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-01-04 | 2022-01-06 | 1,736 | $6.30 | $10.9K | 60,579 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-01-04 | 2022-01-06 | 2,305 | $12.00 | $27.7K | 62,884 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | M Exercise | 2022-01-04 | 2022-01-06 | 1,737 | $6.18 | $10.7K | 58,843 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | F Tax w/h | 2022-01-03 | 2022-03-21 | 820 | $36.73 | $30.1K | 18,992 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise deriv | 2021-12-10 | 2021-12-13 | 2,647 | — | $0 | 611 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | S Sale | 2021-12-10 | 2021-12-13 | 2,647 | $30.88 | $81.7K | 19,812 | SEC↗ |
| Brockstedt Dirk G. | Chief Scientific Officer | M Exercise | 2021-12-10 | 2021-12-13 | 2,647 | $6.30 | $16.7K | 22,459 | SEC↗ |
| HO WILLIAM | Chief Medical Officer | S Sale | 2021-12-03 | 2021-12-06 | 3,000 | $32.26 | $96.8K | 57,106 | SEC↗ |